Cargando…

Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

BACKGROUND: LADA is probably the most prevalent form of autoimmune diabetes. Nevertheless, there are few data about cardiovascular disease in this group of patients. The aim of this study was to investigate the frequency of carotid atherosclerotic plaques in patients with LADA as compared with patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Marta, López, Carolina, Real, Jordi, Valls, Joan, Ortega-Martinez de Victoria, Emilio, Vázquez, Federico, Rubinat, Esther, Granado-Casas, Minerva, Alonso, Nuria, Molí, Teresa, Betriu, Angels, Lecube, Albert, Fernández, Elvira, Leslie, Richard David, Mauricio, Dídac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532780/
https://www.ncbi.nlm.nih.gov/pubmed/28750634
http://dx.doi.org/10.1186/s12933-017-0576-9
_version_ 1783253522021613568
author Hernández, Marta
López, Carolina
Real, Jordi
Valls, Joan
Ortega-Martinez de Victoria, Emilio
Vázquez, Federico
Rubinat, Esther
Granado-Casas, Minerva
Alonso, Nuria
Molí, Teresa
Betriu, Angels
Lecube, Albert
Fernández, Elvira
Leslie, Richard David
Mauricio, Dídac
author_facet Hernández, Marta
López, Carolina
Real, Jordi
Valls, Joan
Ortega-Martinez de Victoria, Emilio
Vázquez, Federico
Rubinat, Esther
Granado-Casas, Minerva
Alonso, Nuria
Molí, Teresa
Betriu, Angels
Lecube, Albert
Fernández, Elvira
Leslie, Richard David
Mauricio, Dídac
author_sort Hernández, Marta
collection PubMed
description BACKGROUND: LADA is probably the most prevalent form of autoimmune diabetes. Nevertheless, there are few data about cardiovascular disease in this group of patients. The aim of this study was to investigate the frequency of carotid atherosclerotic plaques in patients with LADA as compared with patients with classic type 1 diabetes and type 2 diabetes. METHODS: Patients with LADA were matched for age and gender in different proportions to patients with type 2 diabetes, and classic type 1 diabetes. None of the patients had clinical cardiovascular disease. All subjects underwent B-mode carotid ultrasound to detect atheroma plaques. Demographics were obtained from all subjects. RESULTS: We included 71 patients with LADA, 191 patients with type 2 diabetes and 116 patients with type 1 diabetes. Carotid atherosclerosis was more frequent in patients with LADA compared with type 2 diabetes (73.2% vs. 56.9%, P = 0.0018) and classic type 1 diabetes (57.1%, P = 0.026); these changes occurred despite healthier macrovascular risk profiles in the former. Age (P < 0.001), smoking (P = 0.003) and hypertension (P = 0.019) were independently associated with carotid atherosclerosis. Multiple plaques were also more frequent in patients with LADA as compared with classic type 1 diabetes and type 2 diabetes (45.1% and 33.6% vs. 27.2%, respectively, P = 0.022). The frequency of carotid plaques increased with increasing diabetes duration in LADA patients compared with type 2 diabetes (85.7% vs. 58.8%, inverse OR 5.72 [1.5–21.8]; P = 0.009). CONCLUSIONS: LADA patients do not present with less carotid atherosclerosis than patients with type 1 and type 2 diabetes. Their macrovascular risk occurs despite a healthier macrovascular risk profile than those patients with type 2 diabetes.
format Online
Article
Text
id pubmed-5532780
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55327802017-08-02 Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes Hernández, Marta López, Carolina Real, Jordi Valls, Joan Ortega-Martinez de Victoria, Emilio Vázquez, Federico Rubinat, Esther Granado-Casas, Minerva Alonso, Nuria Molí, Teresa Betriu, Angels Lecube, Albert Fernández, Elvira Leslie, Richard David Mauricio, Dídac Cardiovasc Diabetol Original Investigation BACKGROUND: LADA is probably the most prevalent form of autoimmune diabetes. Nevertheless, there are few data about cardiovascular disease in this group of patients. The aim of this study was to investigate the frequency of carotid atherosclerotic plaques in patients with LADA as compared with patients with classic type 1 diabetes and type 2 diabetes. METHODS: Patients with LADA were matched for age and gender in different proportions to patients with type 2 diabetes, and classic type 1 diabetes. None of the patients had clinical cardiovascular disease. All subjects underwent B-mode carotid ultrasound to detect atheroma plaques. Demographics were obtained from all subjects. RESULTS: We included 71 patients with LADA, 191 patients with type 2 diabetes and 116 patients with type 1 diabetes. Carotid atherosclerosis was more frequent in patients with LADA compared with type 2 diabetes (73.2% vs. 56.9%, P = 0.0018) and classic type 1 diabetes (57.1%, P = 0.026); these changes occurred despite healthier macrovascular risk profiles in the former. Age (P < 0.001), smoking (P = 0.003) and hypertension (P = 0.019) were independently associated with carotid atherosclerosis. Multiple plaques were also more frequent in patients with LADA as compared with classic type 1 diabetes and type 2 diabetes (45.1% and 33.6% vs. 27.2%, respectively, P = 0.022). The frequency of carotid plaques increased with increasing diabetes duration in LADA patients compared with type 2 diabetes (85.7% vs. 58.8%, inverse OR 5.72 [1.5–21.8]; P = 0.009). CONCLUSIONS: LADA patients do not present with less carotid atherosclerosis than patients with type 1 and type 2 diabetes. Their macrovascular risk occurs despite a healthier macrovascular risk profile than those patients with type 2 diabetes. BioMed Central 2017-07-28 /pmc/articles/PMC5532780/ /pubmed/28750634 http://dx.doi.org/10.1186/s12933-017-0576-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Hernández, Marta
López, Carolina
Real, Jordi
Valls, Joan
Ortega-Martinez de Victoria, Emilio
Vázquez, Federico
Rubinat, Esther
Granado-Casas, Minerva
Alonso, Nuria
Molí, Teresa
Betriu, Angels
Lecube, Albert
Fernández, Elvira
Leslie, Richard David
Mauricio, Dídac
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
title Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
title_full Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
title_fullStr Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
title_full_unstemmed Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
title_short Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
title_sort preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (lada), type 2 diabetes and classical type 1 diabetes
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532780/
https://www.ncbi.nlm.nih.gov/pubmed/28750634
http://dx.doi.org/10.1186/s12933-017-0576-9
work_keys_str_mv AT hernandezmarta preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT lopezcarolina preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT realjordi preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT vallsjoan preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT ortegamartinezdevictoriaemilio preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT vazquezfederico preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT rubinatesther preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT granadocasasminerva preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT alonsonuria preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT moliteresa preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT betriuangels preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT lecubealbert preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT fernandezelvira preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT lesliericharddavid preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes
AT mauriciodidac preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes